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ABSTRACT 
Background: Epilepsy is defined as the primary disorder of the brain due 
to an abnormal and excessive neuronal activity involving cerebral grey 
matter, resulting in a seizure.  
Objective: The objective was to do a clinical evaluation of Panchagavya 
ghrita in Bal apasmara (epilepsy in paediatric age group). 
Materials and Methods: It is a randomized open interventional parallel 
efficacy drug trial. A total number of 60 patients were selected from the 
age group of 4 years to 16 years of age. All the patients were recently 
diagnosed with Idiopathic type of epilepsy and were not on any kind of 
medication, before the start of the study. The selected patients were 
randomly divided into two groups – The patients in Group I (n = 30) were 
given Panchagavya ghrita and patients in Group II (n = 30) were kept on 
Tab. Tegretol for the study. Both the groups were studied for 12 months to 
see the efficacy of the drug. 
Results: Group I showed Statistically significant results in Frequency of 
convulsions, Duration of convulsion and Smritinasha (Amnesia). Where as 
in Group II highly significant results were observed in Frequency of 
convulsions and duration of convulsion; but not   significant results were 
observed in Smritinasha (Amnesia). 
Conclusion: Panchagavya ghrita has shown promising results in the 
management of Bal - apasmara (Epilepsy in paediatric age group) without 
any complications and side-effects. 
INTRODUCTION 
The incidence and prevalence of epilepsy 
varies in different countries.2-5 It is one of the most 
commonly found neurological disorder in India. India is 
home to nearly 10 million people suffering from 
Epilepsy (Prevalence of about 1%).6 The incidence is 
higher in the rural (1.9%) than in the urban (0.6%) 
part of India.7-8  Epilepsy is a disorder of the brain 
which is characterized by an enduring predisposition 
to generate seizures and by it’s neurological, cognitive, 
psychological and social consequences. Epilepsy is 
defined by international League Against Epilepsy 
(ILAE; 1993) as a condition characterized by recurrent 
(two or more) epileptic seizures, unprovoked by any 
immediate indentified cause.9   
In Ayurveda, Apasmara has been described in many 
classics.10-13 
 Paediatrics has changed enormously 
worldwide in the last three decades. Spectrum of 
infectious diseases is receding and major advances in 
the high technology medicine. are, now curing children. 
Though modern science has developed leaps and 
bounds, the horror of Apasmara (Epilepsy) is still 
among the sufferers as well as among the medical 
fraternity. The word Apasmara (Epilepsy) is a social 
stigma. Even the law of India prevents him or her to 
marry, to drive a car. As per the provisions laid down 
under “Hindu Marriage Act-1955” the sub. Clause (c) of 
sub. Section (ii) of section 5; a man or woman suffering 
from epilepsy cannot marry. This can also be treated as 
a ground for divorce. After understanding the grievance 
of this disease, it becomes a prime duty of a student of 
Ayurveda, Like us, to study the disorder and clinically 
prove the efficiency of a time-tested drug like 
“Panchagavya Ghrita”. For paediatric age group. 
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Acharyas have considered “Graha” as the main culprit, 
for the ailments. Acharya Vagbhata have mentioned 
“Skanda-Apasmara”.14 While describing the signs and 
symptoms of “Skanda-apasmara”, Acharya Vagbhata 
says; the child becomes unconscious repeatedly, eye 
movements are abnormal, frothing is present, becomes 
febrile, smells like fresh blood and becomes insomnic. 
There is a typical pyogenic smell to his/her body.14 
Some scholars of Ayurveda compare this ailment with 
Epilepsy. But signs like, pyogenic or Blood like odour of 
body differs this ailment from what has been described 
as Epilepsy in modern literature. For this clinical work, 
patients are diagnosed as “Apasmara” and treated 
accordingly. The description of Apasmara; including 
etiological background, prodromal signs and 
symptoms, cardinal signs; go very close to the 
description of Epilepsy. So, for clinical evaluation of 
Panchagavya Ghrita, Apasmara is compared with 
Epilepsy in this present study. This research work was 
focused only on the patients from paediatric age group. 
So, for this purpose this ailment was termed as “Bal-
Apasmara.” 
MATERIALS AND METHODS 
Study design: It is a randomized open interventional 
parallel efficacy drug trial. For this study total 60 
patients were taken from OPD of Pakwasa Samnvaya 
Rugnalaya, Nagpur. 
Selection of cases 
Inclusion Criteria 
 Patients having clinical manifestation of Epilepsy 
were thoroughly screened and selected for the 
study. 
 Patients were selected from the age group of 4 
years to 14 years of age. 
 Patients recently diagnosed as Epileptics, i.e., not 
more than 6 months old case; were selected for this 
study. 
 Patients of idiopathic type of Epileptics were 
selected. 
 The diagnostic criteria of epilepsy was in 
accordance with the symptomatology described 
both in Ayurvedic as well as Modern literature, 
duly supported by necessary laboratory 
investigations; including EEG and CT scan. 
Exclusion Criteria  
 Patients having organic or focal epilepsy were 
rejected. 
 Patients presenting other complications like 
Mental Retardation, Meningitis, Tuberculosis, 
Cerebral Palsy etc. were rejected. 
 Patients not regular in the treatment were rejected. 
Trial drug  
A classical preparation of Medicated Ghee called as 
“Panchagavya Ghrita” or “Laghu Panchagavya Ghrita” 
was selected for the study. The reference for this drug 
is taken from Charak Samhita.15 
Contents of Panchagavya Ghrita 
 Gau – Shakrud Rasa (Fresh cow-dung juice) 
 Gau–Dadhi (Cow milk Curd) 
 Gau – Kshira (Fresh cow milk) 
 Gau – mutra (Fresh cow urine) 
 Gau –ghrita (Cow ghee) 
 All the five ingredients were taken in equal 
proportion. The Panchagavya Ghrita was prepared 
according to Ghrita Paka Vidhi. 
Dose: The minimum advised dose was 5ml/day and 
maximum dose was 20ml/day. The Ghrita was advised 
before and after meal twice a day for 12 months. For 
Anupana koshnajala was advised for all the patients. 
Grouping of Patients 
 All the 60 Patients, selected for the study were 
divided into two groups namely, Group I and Group II. 
The Group I and Group II were selected by simple 
random sampling technique. 
Group I (on Panchagavya ghrita) 
 A total of 30 Patients were in this group. They 
were given Panchagavya Ghrita along with luke warm 
water Before and After meal; twice a day. 
Group II (on Tab. Tegretol) 
 A total of 30 Patients were in this group. The 
Patients were advised Tab. Tegretol 1 OD for the period 
of 12 months. 
Criteria of assessment 
 For the assessment of results four symptoms 
were kept as parameters. Out of these four parameters, 
two are subjective and two are objective. 
Subjective Parameters 
1. Smritinasha  (Amnesia) 
2. Avasthikam Tamaha Pravesha (Blackening in front 
of eyes) 
Objective Parameters 
1. Frequency of Convulsions 
2. Duration of Convulsion 
 All the parameters were graded and the 
observations found were expressed accordingly. The 
gradation of parameters  are as below: 
I. Smritinasha (Amnesia) 
3 =  Total Smritinasha to the event. 
2 =  Partial Smritinasha to  the event; recalls few 
details about the event. 
1 =  Partial Smritinasha to the event but recalls 
when thinks about the event. 
0 =  Recalls the event without thinking about it. 
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II. Avasthikam Tamaha Pravesha (Blackening in 
front of eyes) 
1 =  Present 
0 =  Absent 
III. Frequency of Convulsions 
3=  Daily one, two, three or more than three 
attacks. 
2 =  Weekly one, two, three or more than three 
attacks. 
1 =  Monthly one, two, three or more than three 
attacks. 
0 =  Absence of attacks. 
IV. Duration of Convulsion 
3 =  15 minutes or more 
2 =  10 minutes or more 
1 =  5 minutes or more 
0 =  Absence of convulsion 
The observations found on the basis of  gradation of 
these four parameters were recorded as results. The 
result was analysed by the parameters given below:  
I. Relieved =  All the four symptoms are controlled. 
II. Improved = Out of four any three symptoms are 
controlled. 
III. Moderate = Out of four any two or one symptom is 
controlled. 
IV. No Change = None of the symptoms are controlled. 
V. Worsened = Any of the four symptoms intensifies. 
Follow ups 
 Both the groups were studied for 12 months, 
during which patients were observed and observations 
were recorded after the interval of 1 month upto, 12 
months. Patients from both the Groups were advised 
follow-ups after 1 month; after the completion of 12 
months of treatment. 
Statistical analysis 
 All the observations obtained were analysed 
statistically and the inference was drawn according to 
the Mean, Median, SD, SEM and P Value of the 
parameters. Test applied to all four symptoms is one 
way ANOVA, i.e., Kruskal wallies test with Dunn’s 
multiple comparison test. It is a non parametric test, as 
data does not follow normal distribution or Gaussion 
curve. P value summary was taken by comparing with 
baseline before treatment values.(Abbreviations: SD = 
Standard deviation, SE = Standard Eror, P = Actual 
Probability Value, n = number of observations). 
OBSERVATIONS AND RESULTS 
After the study; the observations found in both the 
groups were calculated statistically to find out the 
significance of result. 
Table 1: Showing the distribution of cases 
according to the result obtained, in Group I 
Result No. of cases  
Relieved 14 
Improved 2 
Moderate 3 
No change 11 
Worsened 0 
Table 2: Showing the distribution of cases 
according to the result obtained, in Group II 
Result No. of cases  
Relieved 0 
Improved 10 
Moderate 11 
No change 9 
Worsened 0 
 It is observed that in Group I, 14 patients were 
relieved according to the parameters of this study; 
giving an impressive result of 46.66%. 2 patients were 
improved, 3 patients showed moderate results and 11 
patients had no change in their status. No patients 
showed adverse result to fall in the category named 
worsened. 
 In Group II, no patient was relieved. 11 
patients showed moderate results and 10 patients 
showed improved results. 9 patients had no change in 
their status. 
Table 3: Effect of treatment on clinical symptoms 
 
 
 In Group I, Smritinasha showed 50% relief, 
Avasthikam Tamah Pravesh showed 26.66%, Frequency 
of convulsion showed 51.42% relief and Duration of 
convulsion showed 50% relief. Smritinasha started 
Clinical signs and symptoms  Mean I S. D. P 
B T A T 
Smrutinasha I 2.53 + 0.50 1.30 + 0.70 < 0.001 
II 2.33 + 0.49 2.16 + 0.71 < 0.05 
AvasthikamTamah Pravesha I 1.00+ 0 0.73+ 0.44 > 0.05 
II 1.00+ 0 0.83+ 0.37 > 0.05 
Frequency of convulsions I 2.33 + 0.47 1.13 + 0.73 < 0.001 
II 2.4 + 0.49 1.10 + 0.71 < 0.001 
Duration of convulsion I 2.33 + 0.60 1.13 + 0.77 < 0.001 
II 2.30 + 0.46 1.30 + 0.83 < 0.001 
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showing significant result in 8th month of treatment 
and showed highly significant result in 9th month. 
Avasthikam Tamah Pravesha exhibited non significant 
result till 12th month of treatment. Frequency of 
convulsions was reduced to highly significant level at 
the 10th month of medication. Duration of convulsion 
showed highly significant result at 10th month of the 
study. 
 In Group II, Smritinasha showed 7.14% relief, 
Avasthikam Tamah Pravesha showed 16.66% relief. 
Frequency of convulsions showed 52.77% relief and 
Duration of convulsion showed 42.02% relief. 
Frequency of convulsion showed highly significant 
result at 9th month of treatment. Duration of convulsion 
started showing significant result at 9th month and 
showed highly significant result at 10th month 
treatment. 
DISCUSSION 
 In the present study the incidence of Apasmara 
is found to be comparatively high in the age group of 10 
to 12 years with 46.66%. Out of total 60 patients 65% 
patients belong to poor economic class of society. This 
is interesting to note that unhygienic food, unclean 
environment and pirated surrounding does have its 
effect on personality of a person.16 The disease like 
Apasmara, where these factors are important, this 
observation should be critically studied. 
 While studying the family history of all the 60 
patients; only 15 patients were reported to have 
significant family history. Out of these 15 patients; 4 
patients were having family history of Epilepsy and 
other 3 patients were having family history of 
Tuberculosis. 
 The observations made on the basis of 
premorbid personality traits shows that irritable, bad 
tempered, aggressive, moody, fearing, sleeplessness 
were the dominant traits in the present study. One 
patient is found to exhibit many traits. 
 Nearly 60% patients were complaining of 
Krimi. The worm infestation was a long standing 
problem in those Patients. So, it would be interesting to 
study the correlation between Apasmara and krimi. Out 
of 60; 43 Patients were complaining of Vibhatsacheshta 
as the major hazard. Remaining 17 patients were not 
having any generalized tonic-clonic phases. There were 
partial seizures prominently in those 17 patients. 
Incontinence of urine was found in only 18 patients out 
of total 60 patients. This symptom was found high in 
age group of 7 to 9 years and incidence was high in 
males.  
Probable Mode of Action of Panchagavya Ghrita  
 Before going for action of trial drug, first in 
short understand the Samprapti (Disease pathogenesis) 
of Apasmra. Due to Doshadushtikara diet and 
Manasdushtikara reasons, the bodily Doshas and Mind 
gets vitiated. This causes Jnyanendriyavikriti (Sensory 
derangement) and Karmendriya Vikriti (Motor function 
derangement) in person. The vitiated Dosha remains 
accumulated in body and mind. Whenever the diseased 
individual comes in contact with triggering factor, these 
accumulated vitiated Dosha gets lodged in mind 
resulting in convulsion.17 Vatadosha, Manovahasrotas, 
Sanjnavahasrotas and mind are the major components 
of the pathogenesis. Apasmara is a very deeply rooted 
disease, hence Rasayana Therapy is advised by 
Acharyas.18 Cow milk and cow ghee in particular 
possess the property of Rasayana.19 Cow dung has a 
special quality; Rakshoghna as a Prabhava. Gau-Dadhi 
(cow curd) and Gau-mutra (cow urine) are excellent 
Vataghna. 20-21 
 Panchagavya Ghrita exhibits Rasayana, 
Rakshoghna, Vataghna, Medhya, Smrutikara properties. 
All the components of Panchagavya Ghrita, especially 
cow urine is very rich in volatile free acids which are 
very potent antioxidant agents.22-23 There are many 
evidences to suggest the role of oxidants in the 
causation of epilepsy.24-25 So, when these factors are 
considered together it can be said that by the virtue of 
its anti oxidant action Panchagavya Ghrita offers 
protection against convulsions. 26 
CONCLUSION 
 All the components of Panchagavya Ghrita can 
be easily available throughout the country. Preparation 
of the drug does not require great skill; making it easily 
accessible to anyone. 
 Panchagavya Ghrita showed promising results 
in controlling frequency of convulsions and Duration of 
convulsions. It also showed significant result in 
Avasthikam Tamah Pravesha. Panchagavya Ghrita can 
be given for a long duration of time in therapeutic 
dosage without the fear of any side-effects. 
 Tab. Tegretol reduces Frequency of 
convulsions and Duration of convulsion considerably 
but produces side effects like dizziness and nausea. 
Whereas, Panchagavya ghrita increases alertness and 
activeness and even works as an Agnideepna 
(Improving metabolic fire) medicine. 
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